Liquid Dose Manufacturing

INSIGHTS ON LIQUID DOSE MANUFACTURING

Ensuring Integrity: Testing Viscous Biologics In Pre-Filled Syringes
Viscous biologics in pre-filled syringes demand precise integrity testing. Discover how advanced HVLD technology detects micro-defects and ensures sterility, meeting stringent USP <1207> standards.
Agile Sterile Injectable Filling for Faster Market Entry
CMOs specializing in sterile injectable filling help pharmaceutical companies speed up product development and commercialization through flexible manufacturing, adaptability, and strong collaboration.
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
Lifecycle Planning For Containment And Delivery Of Biologics Drug Products
Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.

Solving The Silicone Challenge In Pre-Fillable Syringes
8/27/2024

Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
Comparing Sterility Testing Techniques
10/21/2024

Is your sterility testing process hindering your product release? Discover how the right approach can streamline your process, reduce false positives, and ultimately save you time and money.
Selecting A Prefillable Syringe System With Confidence
2/5/2026

Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.
Safeguarding Biologic Integrity Through Enhanced Component Compatibility
4/21/2026

For sensitive biologics and viral vectors, risk extends beyond simple contamination. Utilizing inert barrier films on contact surfaces reduces compound migration and adsorption, maintaining dosage accuracy.
Cutting Through Complexity: An Integrated Model For Faster PFS Development
4/7/2026

Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.

Closed Pharmaceutical Restricted Access Barrier System (RABS) From Franz Ziel

Closed RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved through a barrier (cRABS housing with gloves) between the operator and the product.
Sterile Fill/Finish Capability

Through a science-led approach and extensive experience in product development, our team can support you with aseptic and terminally sterilized small volume liquids, as well as ocular and pulmonary delivery.
Enabling The Delivery Of Complex Biologics With Ergonomic Solutions

The BD UltraSafe Plus™ passive needle guard for pre-filled ISO standard glass syringes is designed to support viscous drug delivery with ergonomics and drug visibility.
Low Delamination Propensity Vials

After conducting extensive research on the chemical performance of the glass vial inner surface and the glass forming process parameters, Stevanato Group added SG LDP Vials to its portfolio. These containers are specifically designed to minimize the formation of surface inhomogeneities.
Overcoming Aseptic Manufacturing Challenges To Prevent Contamination

The pharmaceutical industry has steadily moved to increased production and handling of sterile highly potent active ingredients (HPAPIs). Dec’s containment technologies comply with pharmaceutical quality manufacturing standards and are available for aseptic operations.